Medicare spending on cancer drugs may not be associated with the drugs’ clinical benefits, such as overall survival or progression-free survival.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w ...

A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

Cancer treatment costs about $150,000 per patient.  In 2015, spending for cancer treatment and care in the United States was estimated at $183 billion | Cancer ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

An analysis of oncology drugs approved in the United States found that Medicare spending was predominantly driven by the market, not a drug’s therapeutic value.

Prosecutors allege Adam Wayne Owens violated an anti-kickback statute in a scheme to provide genetic cancer testing for ...

Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...

A new study on high-cost drug use in colorectal and non-small cell lung cancer patients found that those with Medicare Advantage plans received less expensive cancer drugs compared to those on ...

The study found Medicare Advantage patients received less expensive cancer drugs, particularly for colorectal cancer, when compared to Traditional Medicare.